Log In
BCIQ
Print this Print this
 

Accofil, Filgrastim

  Manage Alerts
Collapse Summary General Information
Company Intas Pharmaceuticals Ltd.
DescriptionBiosimilar of Neupogen filgrastim, a recombinant methionyl human granulocyte colony-stimulating factor (G-CSF)
Molecular Target Granulocyte colony-stimulating factor (G-CSF) (CSF3)
Mechanism of ActionGranulocyte colony stimulating factor (G-CSF) receptor (CD114) agonist; Biosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationNeutropenia
Indication DetailsTreat neutropenia
Regulatory Designation EU - Biosimilar (Treat neutropenia)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today